These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 30043417)
1. Germline mutations in PPFIBP2 are associated with lethal prostate cancer. Wu Y; Yu H; Zheng SL; Feng B; Kapron AL; Na R; Boyle JL; Shah S; Shi Z; Ewing CM; Wiley KE; Luo J; Walsh PC; Carter HB; Helfand BT; Cooney KA; Xu J; Isaacs WB Prostate; 2018 Dec; 78(16):1222-1228. PubMed ID: 30043417 [TBL] [Abstract][Full Text] [Related]
2. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Wu Y; Yu H; Zheng SL; Na R; Mamawala M; Landis T; Wiley K; Petkewicz J; Shah S; Shi Z; Novakovic K; McGuire M; Brendler CB; Ding Q; Helfand BT; Carter HB; Cooney KA; Isaacs WB; Xu J Prostate; 2018 Jun; 78(8):607-615. PubMed ID: 29520813 [TBL] [Abstract][Full Text] [Related]
3. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Na R; Zheng SL; Han M; Yu H; Jiang D; Shah S; Ewing CM; Zhang L; Novakovic K; Petkewicz J; Gulukota K; Helseth DL; Quinn M; Humphries E; Wiley KE; Isaacs SD; Wu Y; Liu X; Zhang N; Wang CH; Khandekar J; Hulick PJ; Shevrin DH; Cooney KA; Shen Z; Partin AW; Carter HB; Carducci MA; Eisenberger MA; Denmeade SR; McGuire M; Walsh PC; Helfand BT; Brendler CB; Ding Q; Xu J; Isaacs WB Eur Urol; 2017 May; 71(5):740-747. PubMed ID: 27989354 [TBL] [Abstract][Full Text] [Related]
4. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel. Leongamornlert DA; Saunders EJ; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Benafif S; Brook MN; Donovan JL; Hamdy FC; Neal DE; Muir K; Govindasami K; Conti DV; Kote-Jarai Z; Eeles RA Eur Urol; 2019 Sep; 76(3):329-337. PubMed ID: 30777372 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis. Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392 [TBL] [Abstract][Full Text] [Related]
6. Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer. Wu Y; Yu H; Li S; Wiley K; Zheng SL; LaDuca H; Gielzak M; Na R; Sarver BAJ; Helfand BT; Walsh PC; Lotan TL; Cooney KA; Black MH; Xu J; Isaacs WB Eur Urol Oncol; 2020 Apr; 3(2):224-230. PubMed ID: 31948886 [TBL] [Abstract][Full Text] [Related]
8. Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. Wei J; Beebe-Dimmer J; Shi Z; Sample C; Yan G; Rifkin AS; Sadeghpour A; Gielzak M; Choi S; Moon D; Zheng SL; Helfand BT; Walsh PC; Xu J; Cooney KA; Isaacs WB Prostate; 2023 Apr; 83(5):454-461. PubMed ID: 36567534 [TBL] [Abstract][Full Text] [Related]
9. KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression. Xu J; Shi Z; Wei J; Na R; Resurreccion WK; Wang CH; Sample C; Han M; Zheng SL; Cooney KA; Helfand BT; Isaacs WB Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):749-754. PubMed ID: 35149774 [TBL] [Abstract][Full Text] [Related]
10. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. Wei J; Yang W; Shi Z; Lu L; Wang Q; Resurreccion WK; Engelmann V; Zheng SL; Hulick PJ; Cooney KA; Isaacs WB; Helfand BT; Lu J; Xu J Prostate; 2021 Sep; 81(13):1002-1008. PubMed ID: 34254341 [TBL] [Abstract][Full Text] [Related]
11. Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer. Rantapero T; Wahlfors T; Kähler A; Hultman C; Lindberg J; Tammela TL; Nykter M; Schleutker J; Wiklund F Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183364 [TBL] [Abstract][Full Text] [Related]
12. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer. Briollais L; Ozcelik H; Xu J; Kwiatkowski M; Lalonde E; Sendorek DH; Fleshner NE; Recker F; Kuk C; Olkhov-Mitsel E; Savas S; Hanna S; Juvet T; Hunter GA; Friedlander M; Li H; Chadwick K; Prassas I; Soosaipillai A; Randazzo M; Trachtenberg J; Toi A; Shiah YJ; Fraser M; van der Kwast T; Bristow RG; Bapat B; Diamandis EP; Boutros PC; Zlotta AR J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376164 [TBL] [Abstract][Full Text] [Related]
13. Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer. Carter HB; Helfand B; Mamawala M; Wu Y; Landis P; Yu H; Wiley K; Na R; Shi Z; Petkewicz J; Shah S; Fantus RJ; Novakovic K; Brendler CB; Zheng SL; Isaacs WB; Xu J Eur Urol; 2019 May; 75(5):743-749. PubMed ID: 30309687 [TBL] [Abstract][Full Text] [Related]
14. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. Darst BF; Dadaev T; Saunders E; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Gapstur SM; Stevens V; Albanes D; Weinstein SJ; Gnanapragasam V; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz M; Schmidt JA; Mucci L; Catalona WJ; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Kote-Jarai Z; Conti DV; Haiman CA J Natl Cancer Inst; 2021 May; 113(5):616-625. PubMed ID: 32853339 [TBL] [Abstract][Full Text] [Related]
15. The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients. Na R; Wei J; Sample CJ; Gielzak M; Choi S; Cooney KA; Rabizadeh D; Walsh PC; Zheng LS; Xu J; Isaacs WB Br J Cancer; 2022 Mar; 126(5):791-796. PubMed ID: 34799695 [TBL] [Abstract][Full Text] [Related]
16. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients. Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238 [TBL] [Abstract][Full Text] [Related]
17. Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis. Shi Z; Lu L; Resurreccion WK; Yang W; Wei J; Wang Q; Engelmann V; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Lu J; Xu J Prostate; 2022 Jan; 82(1):107-119. PubMed ID: 34674288 [TBL] [Abstract][Full Text] [Related]
18. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. Karyadi DM; Zhao S; He Q; McIntosh L; Wright JL; Ostrander EA; Feng Z; Stanford JL Int J Cancer; 2015 May; 136(9):2166-71. PubMed ID: 25273821 [TBL] [Abstract][Full Text] [Related]
19. Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Rocca C; Rocca G; Zampieri P; Dell'atti L; Bianchi N; Ippolito C; Aguiari G Anticancer Res; 2023 Jul; 43(7):2941-2949. PubMed ID: 37351993 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]